|
1.
|
|
8 p, 477.0 KB |
Chronic kidney disease is a key risk factor for severe COVID-19 : A call to action by the ERA-edta
/
Ortiz, Alberto (Fundacion Jimenez Diaz) ;
Cozzolino, Mario (University of Milan. Department of Health Sciences Renal Division. ASST Santi Paolo e Carlo) ;
Duivenvoorden, Raphaël (Department of Nephrology. Radboud University Medical Center) ;
Fliser, Danilo (Internal Medicine IV. Renal and Hypertensive Disease. University Medical Center) ;
Fouque, Denis (Department of Nephrology. Dialysis. Nutrition. Centre Hospitalier Lyon Sud) ;
Franssen, Casper F.M. (Department of Nephrology. University Medical Center Groningen. University Hospital Groningen) ;
Goumenos, Dimitrios (Department of Nephrology and Renal Transplantation. Patras University Hospital) ;
Hemmelder, Marc H. (Department of Internal Medicine. Maastricht University Medical Center) ;
Hilbrands, Luuk B. (Department of Nephrology. Radboud University Medical Center) ;
Jager, Kitty J. (ERA-EDTA Registry. Dept. Medical Informatics. Amsterdam University Medical Center. Amsterdam Public Health Research Institute) ;
Massy, Ziad A. (Centre for Research in Epidemiology and Population Health (CESP). INSERM UMRS 1018. UniversitÕ Paris-Saclay. UniversitÕ Versailles Saint Quentin (UVSQ)) ;
Noordzij, Marlies (Department of Nephrology. University Medical Center Groningen. University Hospital Groningen) ;
Rosenkranz, Alexander R. (Department of Internal Medicine. Division of Nephrology. Medical University of Graz) ;
Rychlık, Ivan (Department of Internal Medicine. Third Faculty of Medicine. Charles University. Faculty Hospital KrÃlovskÕ Vinohrady) ;
Soler, Maria Jose (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Stevens, Kate (Glasgow Renal and Transplant Unit. Queen Elizabeth University Hospital) ;
Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ;
Tuglular, Serhan (Division of Nephrology. Department of Internal Medicine. School of Medicine. Marmara University) ;
Vart, Priya (University Medical Centre Groningen. University Hospital Groningen) ;
Wanner, Christoph (University of Würzburg. Division of Nephrology) ;
Gansevoort, Ron T. (University Medical Center Groningen. Department of Nephrology. University Hospital Groningen) ;
Universitat Autònoma de Barcelona
Diabetes, hypertension and cardiovascular disease have been listed as risk factors for severe coronavirus disease 2019 (COVID-19) since the first report of the disease in January 2020. However, this report did not mention chronic kidney disease (CKD) nor did it provide information on the relevance of estimated glomerular filtration rate (eGFR) or albuminuria. [...]
2021 -  10.1093/NDT/GFAA314
Nephrology Dialysis Transplantation, Vol. 36 Núm. 1 (2021) , p. 87-94
|
|
|
2.
|
|
8 p, 961.6 KB |
External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury
/
Bagshaw, Sean M. (University of Alberta) ;
Al-Khafaji, Ali (University of Pittsburgh) ;
Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Davison, Danielle (George Washington University) ;
Haase, Michael (Otto Von-Guericke-University Magdeburg) ;
Lissauer, Matthew (Rutgers-Robert Wood Johnson Medical School) ;
Zacharowski, Kai (Goethe University) ;
Chawla, Lakhmir S. (Veterans Affairs Medical Center) ;
Kwan, Thomas (Astute Medical (Estats Units d'Amèrica)) ;
Kampf, J. Patrick (Astute Medical (Estats Units d'Amèrica)) ;
McPherson, Paul (Astute Medical (Estats Units d'Amèrica)) ;
Kellum, John A. (University of Pittsburgh) ;
Universitat Autònoma de Barcelona
Persistent acute kidney injury (AKI) portends worse clinical outcomes and remains a therapeutic challenge for clinicians. A recent study found that urinary C-C motif chemokine ligand 14 (CCL14) can predict the development of persistent AKI. [...]
2021 - 10.1186/s13054-021-03618-1
Critical Care, Vol. 25 (may 2021)
|
|
|
3.
|
|
15 p, 1.1 MB |
Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?
/
Hughes, Derralynn A. (University College London) ;
Aguiar, Patrício (Lisbon University) ;
Lidove, Olivier (Croix Saint Simon Hospital, Paris) ;
Nicholls, Kathleen (University of Melbourne) ;
Nowak, Albina (University Hospital Zurich (Suïssa)) ;
Thomas, Mark (Cincinnati Children's Hospital Medical Center (CCHMC). Center for Fetal and Placental Research) ;
Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ;
Vujkovac, Bojan (General Hospital Slovenj Gradec) ;
West, Michael L. (Dalhousie University) ;
Feriozzi, Sandro (Belcolle Hospital) ;
Universitat Autònoma de Barcelona
Variable disease progression confounds accurate prognosis in Fabry disease. Evidence supports the long-term benefit of early intervention with disease-specific therapy, but current guidelines recommend treatment initiation based on signs that may present too late to avoid irreversible organ damage. [...]
2022 - 10.1186/s13023-022-02181-4
Orphanet Journal of Rare Diseases, Vol. 17 (february 2022)
|
|
|
4.
|
|
14 p, 543.2 KB |
Finding the Dose for Ceftolozane-Tazobactam in Critically Ill Children with and without Acute Kidney Injury
/
Butragueño-Laiseca, Laura (Instituto de Salud Carlos III) ;
Troconiz, Iñaki (Instituto de Investigación Sanitaria de Navarra) ;
Grau, Santiago (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Campillo, Núria (Hospital del Mar (Barcelona, Catalunya)) ;
García-González, Xandra (Hospital General Universitario Gregorio Marañón) ;
Padilla, Belén (Hospital General Universitario Gregorio Marañón) ;
Fernández, Sarah N. (Instituto de Salud Carlos III) ;
Santiago, María José (Instituto de Salud Carlos III)
Background: Ceftolozane-tazobactam is a new antibiotic against multidrug-resistant pathogens such as Pseudomonas aeruginosas. Ceftolozane-tazobactam dosage is still uncertain in children, especially in those with renal impairment or undergoing continuous renal replacement therapy (CRRT). [...]
2020 - 10.3390/antibiotics9120887
Antibiotics, Vol. 9 (december 2020)
|
|
|
5.
|
|
11 p, 6.0 MB |
Cardio-renal outcomes with long-term agalsidase alfa enzyme replacement therapy : A 10-year fabry outcome survey (FOS) analysis
/
Ramaswami, Uma (Royal Free London NHS Foundation Trust. Lysosomal Disorders Unit. Institute of Immunity and Transplantation) ;
Beck, Michael (Centre for Paediatric and Adolescent Medicine. University Medical Centre. University of Mainz) ;
Hughes, D. (Royal Free London NHS Foundation Trust. Lysosomal Disorders Unit. Institute of Immunity and Transplantation) ;
Kampmann, C. (Centre for Paediatric and Adolescent Medicine. University Medical Centre. University of Mainz) ;
Botha, J. (Department of Biostatistics and Programming. Takeda) ;
Pintos-Morell, Guillem (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
West, M. L. (Department of Medicine. Dalhousie University) ;
Niu, D. M. (Department of Paediatrics. Taipei Veterans General Hospital) ;
Nicholls, K. (Royal Melbourne Hospital (Melbourne, Austràlia)) ;
Giugliani, R. (Medical Genetics Service HCPA. Department of Genetics. UFRGS. INAGEMP) ;
Universitat Autònoma de Barcelona
Purpose: Following the publication of 5-year agalsidase alfa enzyme replacement therapy (ERT) outcomes data from the Fabry Outcome Survey (FOS), 10-year data were analyzed. Patients and methods: FOS (ClinicalTrials. [...]
2019 - 10.2147/DDDT.S207856
Drug Design, Development and Therapy, Vol. 13 (2019) , p. 3705-3715
|
|
|
6.
|
|
7 p, 412.7 KB |
Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease : A Fabry Outcome Survey analysis
/
Beck, Michael (University Medical Center, University of Mainz, Department of Paediatrics) ;
Hughes, Derralynn A (Royal Free London NHS Foundation Trust, University College of London) ;
Kampmann, Christoph (University Medical Center, University of Mainz, Department of Paediatrics) ;
Larroque, Sylvain (Shire, Zug) ;
Mehta, Atul (Royal Free London NHS Foundation Trust, University College of London) ;
Pintos-Morellell, Guillem (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ramaswami, Uma (Royal Free London NHS Foundation Trust, University College of London) ;
West, Michael (Department of Medicine, Dalhousie University) ;
Wijatyk, Anna (Shire) ;
Giugliani, Roberto (Medical Genetics Service HCPA/Dep Genet UFRGS and INAGEMP, Porto Alegre) ;
Universitat Autònoma de Barcelona
Outcomes from 5 years of treatment with agalsidase alfa enzyme replacement therapy (ERT) for Fabry disease in patients enrolled in the Fabry Outcome Survey (FOS) were compared with published findings for untreated patients with Fabry disease. [...]
2015 - 10.1016/j.ymgmr.2015.02.002
Molecular Genetics and Metabolism Reports, Vol. 3 (march 2015) , p. 21-27
|
|
|
7.
|
|
14 p, 1.2 MB |
Renal replacement therapy in Europe : a summary of the 2012 ERA-EDTA Registry Annual Report
/
Pippias, Maria (Universiteit van Amsterdam. Department of Informatics) ;
Stel, Vianda S. (Universiteit van Amsterdam. Department of Informatics) ;
Abad Diez, José Maria (Dirección General de Planificación y Aseguramiento. Gobierno de Aragón) ;
Afentakis, Nikolaos (General Hospital of Athens'G. Gennimatas'. Hellenic Renal Registry, Board of Registry, Coordination and Control of RRT) ;
Herrero-Calvo, Jose Antonio (Registro Madrileño de Enfermos Renales (REMER), Sociedad Madrileña de Nefrología) ;
Arias, Manuel (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Tomilina, Natalia (Moscow City Nephrology Center) ;
Bouzas Caamaño, Encarnación (Oficina de Coordinación de Trasplantes, Servicio Gallego de Salud (SERGAS)) ;
Buturovic-Ponikvar, Jadranka (University Medical Center Ljubljana) ;
Čala, Svjetlana (Croatian Society of Nephrology, Dialysis and Transplantation, Zagreb) ;
Caskey, Fergus (School of Social Medicine, Canynge Hall, University of Bristol) ;
Castro de la Nuez, Pablo (Sistema de Información de la Coordinación Autonómica de Trasplantes de Andalucía) ;
Cernevskis, Harijs (Riga Stradins University) ;
Collart, Frederic (French-Belgian ESRD Registry) ;
Alonso de la Torre, Ramón (Public Health Directorate) ;
García Bazaga, María de los Ángeles (Servicio Extremeño de Salud. Consejería de Salud y Política Social) ;
De Meester, Johan (Dutch-speaking Belgian Renal Registry (NBVN)) ;
Díaz Gómez, Juan Manuel (Institut d'Investigació Biomèdica Sant Pau) ;
Djukanovic, Ljubica (School of Medicine, University of Belgrade) ;
Ferrer-Alamar, Manuel (Registro de Enfermos Renales Comunitat Valenciana) ;
Finne, Patrik (Finnish Registry for Kidney Diseases, Helsinki) ;
Garneata, Liliana ('Dr Carol Davila' Teaching Hospital of Nephrology) ;
Golan, Eliezer (Meir Medical Center, Kfar-Saba and Sackler Faculty of Medicine) ;
González Fernández, Raquel (Coordinación Autonómica de Trasplantes de Castilla y León) ;
Gutiérrez Avila, Gonzalo (Registro de Enfermos Renales en Tratamiento Sustitutivo de Castilla-La Mancha) ;
Heaf, James G. (University of Copenhagen) ;
Hoitsma, Andries (Radboud University Medical Center) ;
Kantaria, Nino (Tbilisi State Medical University) ;
Kolesnyk, Mykola (URDS) ;
Kramar, Reinhard (Austrian Dialysis and Transplant Registry) ;
Kramer, Anneke (Universiteit van Amsterdam. Department of Informatics) ;
Lassalle, Mathilde (REIN Registry, Agence de la Biomédecine) ;
Leivestad, Torbjørn (Oslo University Hospital (Oslo, Noruega)) ;
Lopot, Frantisek (Charles University. Department of Medicine) ;
Macario, Fernando (Centro Hospitalar e Universitário de Coimbra (Coimbra, Portugal)) ;
Magaz, Ángela (Comunidad Autónoma del País Vasco. Unidad de Información Sobre Pacientes Renales) ;
Martín-Escobar, Eduardo (Registro Español de Enfermos Renales (REER)) ;
Metcalfe, Wendy (The Scottish Renal Registry, Meridian Court) ;
Noordzij, Marlies (Universiteit van Amsterdam. Department of Informatics) ;
Palsson, Runolfur (University of Iceland. School of Health Sciences) ;
Pechter, Ülle (Tartu University) ;
Prütz, Karl G. (Hospital of Helsingborg) ;
Ratkovic, Marina (Clinical Center of Montenegro) ;
Resić, Halima (University of Sarajevo) ;
Rutkowski, Boleslaw (Medical University) ;
Santiuste de Pablos, Carmen (Registro de Enfermos Renales de la Región de Murcia) ;
Spustová, Viera (Slovak Medical University) ;
Süleymanlar, Gültekin (Istanbul University) ;
Van Stralen, Karlijn (Universiteit van Amsterdam. Department of Informatics) ;
Thereska, Nestor (University Hospital Center, 'Mother Tereza') ;
Wanner, Christoph (University of Würzburg) ;
Jager, Kitty J. (Universiteit van Amsterdam. Department of Informatics) ;
Universitat Autònoma de Barcelona
This article summarizes the 2012 European Renal Association-European Dialysis and Transplant Association Registry Annual Report (available at ) with a specific focus on older patients (defined as ≥65 years). [...]
2015 - 10.1093/ckj/sfv014
Clinical Kidney Journal, Vol. 8 (march 2015) , p. 248-261
|
|
|
8.
|
|
8 p, 343.5 KB |
Renal replacement therapy in ADPKD patients : a 25-year survey based on the Catalan registry
/
Martínez, Víctor (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Comas, Jordi (Organització Catalana de Trasplantaments) ;
Arcos, Emma (Organització Catalana de Trasplantaments) ;
Díaz Gómez, Juan Manuel (Fundació Puigvert) ;
Muray, Salomé (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Cabezuelo, Juan (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Ballarín Castan, José Aurelio (Organització Catalana de Trasplantaments) ;
Ars, Elisabet (Fundació Puigvert) ;
Torra Balcells, Roser (Fundació Puigvert)
Background: Some 7-10% of patients on replacement renal therapy (RRT) are receiving it because of autosomal dominant polycystic kidney disease (ADPKD). The age at initiation of RRT is expected to increase over time. [...]
2013 - 10.1186/1471-2369-14-186
BMC Nephrology, Vol. 14, N. 186 (September 2013) , p. 1-8
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
